Literature DB >> 1449917

Fall in pulmonary vascular resistance in patients awaiting heart transplantation.

S C Grant1, R D Levy, N H Brooks.   

Abstract

BACKGROUND: Raised pulmonary vascular resistance is associated with decreased survival after orthotopic heart transplantation and patients with this risk factor are usually denied transplantation. In a proportion of cases raised pulmonary vascular resistance may fall with time and medical treatment.
METHODS: Seven patients with high pulmonary vascular resistance (range 3.9-6.6 Wood units) at initial assessment for cardiac transplantation were restudied by right heart catheterisation after a period of seven to 17 months.
RESULTS: In five of the seven patients the pulmonary vascular resistance had fallen, allowing orthotopic heart transplantation to be performed in four. In one patient the resistance was static and in one it had risen. The mean fall in pulmonary vascular resistance for the group was (mean (SD)) 2.6 (2.7) Wood units, p < 0.05.
CONCLUSION: Patients who have been denied transplantation on the basis of their raised pulmonary vascular resistance should be reassessed after four to six months if they remain otherwise clinically suitable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449917      PMCID: PMC1025133          DOI: 10.1136/hrt.68.10.365

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  8 in total

1.  Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.

Authors:  K W Erickson; M R Costanzo-Nordin; E J O'Sullivan; M R Johnson; M J Zucker; R Pifarré; C E Lawless; J A Robinson; P J Scanlon
Journal:  J Heart Transplant       Date:  1990 Sep-Oct

2.  Improved evaluation of pulmonary vascular resistance prior to heart transplantation.

Authors:  G Dreyfus; V A Jebara; R Guillemain; C Amrein; A F Carpentier
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantation.

Authors:  G M Deeb; S F Bolling; T P Guynn; J M Nicklas
Journal:  Ann Thorac Surg       Date:  1989-11       Impact factor: 4.330

4.  Indications for cardiac transplantation.

Authors:  P M Schofield
Journal:  Br Heart J       Date:  1991-01

5.  Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.

Authors:  A Costard-Jäckle; M B Fowler
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

6.  Determinants of operative risk in human heart transplantation.

Authors:  R B Griepp; E B Stinson; E Dong; D A Clark; N E Shumway
Journal:  Am J Surg       Date:  1971-08       Impact factor: 2.565

7.  Analysis of morbid events and risk factors for death after cardiac transplantation.

Authors:  J K Kirklin; D C Naftel; D C McGiffin; R F McVay; E H Blackstone; R B Karp
Journal:  J Am Coll Cardiol       Date:  1988-05       Impact factor: 24.094

8.  Effects of heart rate on ventricular size, stroke volume, and output in the normal human fetus: a prospective Doppler echocardiographic study.

Authors:  J Kenny; T Plappert; P Doubilet; D Salzman; M G Sutton
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.